Axcan Pharma US Inc.
Division of Allergan PLC
Latest From Axcan Pharma US Inc.
Xenon Pharmaceuticals, a clinical-stage biopharmaceutical company, has named Steven Gannon to its board of directors; he will also serve on the company's audit committee. Mr Gannon is a senior financial executive whose executive and board experience spans the pharmaceutical industry, and includes corporate finance and strategic transactions, mergers and acquisitions, business and corporate development and commercial operations. His past executive experience includes serving as chief financial officer, senior vice-president of finance, and treasurer at Aptalis Pharma (formerly Axcan Pharma).
In a deal that proves just what can be done when all shareholders can be consulted in a single elevator journey, Endo International and privately owned Par Pharmaceutical have put together a $8.05bn merger to create the fifth largest independent company in the generics pharmaceutical space. And the deal makes Teva's bid for Mylan look somewhat underpowered.
The specialty pharma makes its first acquisition of the New Year, tucking in gastrointestinal and cystic fibrosis franchises, which bolster its current therapeutic area offerings.
The days before and after Christmas weren’t completely devoid of news. A pair of companies announced plans for initial public offerings, including an IPO for private equity-backed Aptalis. An antibacterial drug developer raised $18 million in a private financing, while a company testing a multiple sclerosis therapy raised $8 million in a secondary offering. A small oncology specialist said it raised more than $3 million in an add-on offering. And Shire extended its tender offer for the $4.2 billion takeover of ViroPharma.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Allergan PLC
- Senior Management
- Contact Info
Axcan Pharma US Inc.
Phone: (612) 417-0684
3940 Quebec Ave., North
Minneapolis, MN 55427
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.